Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03759184
Brief Title: Human IL-15 (rhIL-15) and Obinutuzumab for Relapsed and Refractory Chronic Lymphocyte Leukemia

First Submitted : November 28, 2018
First Submitted that Met QC Criteria : November 28, 2018
First Posted : November 29, 2018

Last Update Submitted that Met QC Criteria : July 13, 2019
Last Update Posted : July 16, 2019